Randhir Jesudoss, MD
Gastroenterology · Iowa City, IANPI 1033418843
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,330, 3.4 times the $393 reported in 2023.
Across 60 payments — averaging $42.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$510
- Medtronic$247
- Fujifilm Healthcare Americas Corporation$223
- Johnson & Johnson$197
- Ardelyx, Inc.$190
- Amgen$145
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $510 |
| Medtronic | 4 | $247 |
| Fujifilm Healthcare Americas Corporation | 2 | $223 |
| Johnson & Johnson | 7 | $197 |
| Ardelyx, Inc. | 4 | $190 |
| Amgen | 1 | $145 |
| E.r. Squibb & Sons, L.L.C. | 1 | $126 |
| Gilead | 6 | $125 |
| Sanofi | 4 | $124 |
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $104 |
| Janssen Scientific Affairs, LLC | 1 | $74 |
| AbbVie | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Novo Nordisk | 2 | $40 |
| Ambu Inc. | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Pfizer | 1 | $20 |
| Axonics, Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Valinor Pharma, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,571 in reported general payments places this provider in the 80th percentile of 113 gastroenterology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpclusaSofosbuvir/Velpatasvir | 13 | $320,204 |
| XifaxanRifaximin | 21 | $73,901 |
| LinzessLinaclotide | 19 | $13,056 |
| Sucralfate | 52 | $2,000 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 18 | $1,087 |
| Omeprazole | 82 | $934 |
| Pantoprazole Sodium | 40 | $422 |
| Carvedilol | 12 | $249 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 14 | $220 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadEpclusa | $125 | $320,20413 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $104 | $73,90121 claims |
| AbbVieLinzess | $67 | $13,05619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 113 gastroenterology providers in Iowa.
Other gastroenterology in Iowa City
- Maen MasadehIowa City$24K
- Steven PolyakIowa City$5K
- Ahamed KhalyfaIowa City$3K
- Abdullah AbbasiIowa City$2K
- Gopala KoneruIowa City$2K
- Yehudith Assouline-DayanIowa City$1K
- Rohit NathaniIowa City$1K
- Rami El AbiadIowa City$1K
- Mohamad MokademIowa City$1K
- Rintaro HashimotoIowa City$945
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.